Press Releases

Share
and/or
489 News Releases found
Publicis Foundation launches Working With Cancer to erase the stigma of cancer in the workplace
In a world where one in every two people will be diagnosed with cancer in their lifetime, the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including Memorial Sloan Kettering Cancer Center (MSK), MacMillan Cancer Support and the Gustave Roussy Institute.
Statement Regarding Reduction in Force
As announced in November, as a result of financial challenges that persist across the healthcare industry, Memorial Sloan Kettering Cancer Center (MSK) is reducing its workforce.
David G. Pfister, MD (left) and Sabiha Raoof, MD (right)
Memorial Sloan Kettering Cancer Center and MediSys Health Network Announce New Collaboration to Enhance Cancer Care in Queens
Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.
MSK Awards & Appointments December 2022
MSK Awards & Appointments December 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
A rendering of Memorial Medical Care, PC
New Cancer Care Facility Opens in Brooklyn
Memorial Medical Care, PC, a practice of Memorial Sloan Kettering Cancer Center physicians, in collaboration with New York Cancer & Blood Specialists (NYCBS), recently announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn.
MSK Awards & Appointments November 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.
Jeffrey Zwicker, MD
Jeffrey Zwicker Joins Memorial Sloan Kettering Cancer Center as Chief of the Hematology Service
Jeffrey Zwicker, MD, has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and Beth Israel Deaconess Medical Center (BIDMC), where he served as Chief of Benign Hematology in the Division of Hematology since 2017. Dr. Zwicker succeeds MSK’s Interim Hematology Service Chief, Marcel van den Brink, MD, PhD.
Physician reviewing electronic medical records.
Memorial Sloan Kettering Cancer Center Selects Epic to Transform Electronic Health Record System
Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.
Lawrence Schwartz, MD
Memorial Sloan Kettering Cancer Center Names Lawrence Schwartz, MD, New Chair of the Department of Radiology
Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging, artificial intelligence in cancer imaging, and for his pioneering work in the development and validation of novel imaging biomarkers in oncology.
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
A Fred's Team runner
Fred's Team Makes History by Raising $100 Million for Cancer Research
Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.
Eli L. Diamond, MD and Omar Abdel-Wahab, MD
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.
MSK Awards & Appointments October 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
Carol Morris, MD, MS
Carol Morris Named Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center
Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK).
Left to right: Eileen M. O'Reilly, MD, Christine A. Iacobuzio-Donahue, MD, PhD
Memorial Sloan Kettering Cancer Center Receives NCI SPORE Grant to Improve Outcomes for Patients with Pancreatic Cancer
Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the National Cancer Institute (NCI).
Sloan Kettering Institute’s Alexander Gitlin
Sloan Kettering Institute’s Alexander Gitlin Honored with Prestigious NIH Director’s Early Independence Award
Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.
MSK Awards & Appointments September 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.
Memorial Sloan Kettering Cancer Center Creates Innovative Telemedicine Platform to Provide Patients Greater Access to Care
Memorial Sloan Kettering Cancer Center (MSK) is marking a year since the launch of MSK Telemedicine – an online solution for remote care that has been ...
Francesca Gany
MSK Receives Grant to Help Increase Cancer Outcomes Equity in New York Region
The funding will support patient navigation, essential needs, telemedicine, and psychosocial support services, including language translation and interpretation.